Literature DB >> 23025994

Duration of untreated psychosis and negative symptoms--a systematic review and meta-analysis of individual patient data.

Nynke Boonstra1, Rianne Klaassen, Sjoerd Sytema, Max Marshall, Lieuwe De Haan, Lex Wunderink, Durk Wiersma.   

Abstract

BACKGROUND: Longer duration of untreated psychosis (DUP) is associated with poorer outcome in terms of positive symptoms, relapse rate, and time to remission. In contrast, the association with negative symptoms is less consistent. AIMS: The study had three aims. First, to arrive at a more precise estimate of the correlation between DUP and negative symptoms than previous reviews, by substantially increasing the amount of available data. Second, to see whether the strength of this correlation attenuated over longer follow-up intervals. Third, to determine whether there is a relationship between DUP and changes in negative symptoms.
METHOD: Relevant databases were searched for studies published between December 1992 and March 2009 that reported data on DUP and negative symptoms. We obtained individual patient data where possible and calculated summary correlations between DUP and negative symptoms for each study at baseline, short and long-term follow-up. We used multilevel regression analysis to examine whether the effect of DUP on negative symptoms was the greatest in the early stages of illness.
RESULTS: We included 28 non-overlapping studies from the 402 papers detected by the search strategy. After contacting the authors we obtained individual patient data from 16 of these studies involving 3339 participants. The mean DUP was 61.4 weeks (SD=132.7, median DUP=12.0). Shorter DUP was significantly associated with less severe negative symptoms at baseline and also at short (1-2 years) and longer term follow-up (5-8 years) (r=0.117, 0.180 and 0.202 respectively, p<0.001). The relationship between improvement in negative symptoms and DUP was found to be non-linear: people with a DUP shorter than 9 months showed substantially greater negative symptom reduction than those with a DUP of greater than 9 months.
CONCLUSIONS: Shorter DUP is associated with less severe negative symptoms at short and long-term follow up, especially when the DUP is less than 9 months. Since there is no effective treatment for negative symptoms, reducing DUP to less than 9 months may be the best way to ameliorate them.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23025994     DOI: 10.1016/j.schres.2012.08.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  43 in total

Review 1.  Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review.

Authors:  Selene R T Veerman; Peter F J Schulte; Lieuwe de Haan
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

2.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

3.  Anosognosia in schizophrenia: hidden in plain sight.

Authors:  Douglas S Lehrer; Jennifer Lorenz
Journal:  Innov Clin Neurosci       Date:  2014-05

Review 4.  Attenuated psychosis syndrome in DSM-5.

Authors:  Ming T Tsuang; Jim Van Os; Rajiv Tandon; Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel E Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; William Carpenter
Journal:  Schizophr Res       Date:  2013-06-14       Impact factor: 4.939

5.  Clinical and demographic correlates of stigma in first-episode psychosis: the impact of duration of untreated psychosis.

Authors:  K T Mueser; N R DeTore; M A Kredlow; M L Bourgeois; D L Penn; K Hintz
Journal:  Acta Psychiatr Scand       Date:  2019-10-11       Impact factor: 6.392

6.  [Services for the early recognition of psychoses and bipolar disorders in Germany: inventory survey study].

Authors:  K Leopold; A Nikolaides; M Bauer; A Bechdolf; C U Correll; F Jessen; G Juckel; A Karow; M Lambert; J Klosterkötter; S Ruhrmann; S Pfeiffer; A Pfennig
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

Review 7.  Evidence-based psychotherapy for the prevention and treatment of first-episode psychosis.

Authors:  Hendrik Müller; Sonja Laier; Andreas Bechdolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

8.  Stigma in Mental Health at the Macro and Micro Levels: Implications for Mental Health Consumers and Professionals.

Authors:  Sharon M Holder; Eunice R Peterson; Rebecca Stephens; Lee A Crandall
Journal:  Community Ment Health J       Date:  2018-08-01

9.  Service Use Following First-Episode Schizophrenia Among Commercially Insured Youth.

Authors:  Todd P Gilmer; Els van der Ven; Ezra Susser; Lisa B Dixon; Mark Olfson
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

10.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.